Treatment of branch retinal vein occlusion induced macular edema with bevacizumab

Abegg, Mathias; Tappeiner, Christoph; Wolf-Schnurrbusch, Ute; Barthelmes, Daniel; Wolf, Sebastian; Fleischhauer, Johannes (2008). Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC ophthalmology, 8(18), p. 18. London: BioMed Central 10.1186/1471-2415-8-18

[img]
Preview
Text
1471-2415-8-18.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (2MB) | Preview

Branch retinal vein occlusion is a frequent cause of visual loss with currently insufficient treatment options. We evaluate the effect of Bevacizumab (Avastin) treatment in patients with macular edema induced by branch retinal vein occlusion.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Abegg, Mathias, Tappeiner, Christoph, Wolf-Schnurrbusch, Ute, Barthelmes, Daniel, Wolf, Sebastian (B), Fleischhauer, Johannes M.C.

ISSN:

1471-2415

ISBN:

18823536

Publisher:

BioMed Central

Language:

English

Submitter:

Christoph Tappeiner

Date Deposited:

04 Oct 2013 15:05

Last Modified:

05 Dec 2022 14:20

Publisher DOI:

10.1186/1471-2415-8-18

PubMed ID:

18823536

Web of Science ID:

000208013900018

BORIS DOI:

10.7892/boris.28219

URI:

https://boris.unibe.ch/id/eprint/28219 (FactScience: 118868)

Actions (login required)

Edit item Edit item
Provide Feedback